Bank Mandiri (Persero) Toekomstige groei

Future criteriumcontroles 3/6

Bank Mandiri (Persero) zal naar verwachting groeien in winst en omzet met respectievelijk 8.9% en 12.3% per jaar. De winst per aandeel zal naar verwachting groeien met 8.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 20.9% zijn.

Belangrijke informatie

8.9%

Groei van de winst

8.4%

Groei van de winst per aandeel

Banks winstgroei	10.7%
Inkomstengroei	12.3%
Toekomstig rendement op eigen vermogen	20.9%
Dekking van analisten	Good
Laatst bijgewerkt	04 Nov 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

IDX:BMRI - Toekomstschattingen van analisten en financiële gegevens uit het verleden (IDR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	179,479,477	70,147,309	N/A	N/A	16
12/31/2025	162,870,855	63,150,044	N/A	N/A	19
12/31/2024	146,984,317	56,896,435	N/A	N/A	16
9/30/2024	133,704,511	58,013,868	-247,192,818	-240,457,903	N/A
6/30/2024	131,621,491	56,378,810	-217,594,707	-211,952,550	N/A
3/31/2024	128,598,922	55,202,064	-181,215,954	-175,753,838	N/A
12/31/2023	127,454,571	55,060,057	-160,586,383	-155,565,347	N/A
9/30/2023	121,698,513	49,581,394	-122,962,368	-118,492,049	N/A
6/30/2023	116,231,734	46,193,314	-120,233,192	-115,218,429	N/A
3/31/2023	113,260,546	43,699,281	-91,161,724	-86,465,368	N/A
12/31/2022	109,397,530	41,170,637	-107,337,350	-102,237,704	N/A
9/30/2022	102,443,935	39,451,866	-94,063,860	-89,157,274	N/A
6/30/2022	96,806,573	35,736,231	-44,302,184	-40,357,034	N/A
3/31/2022	91,678,472	32,141,309	-15,312,962	-11,137,464	N/A
12/31/2021	86,552,332	28,028,155	-21,425,351	-17,788,756	N/A
9/30/2021	84,846,745	22,000,577	-12,368,369	-8,322,534	N/A
6/30/2021	77,853,475	19,007,810	-78,339,869	-74,088,512	N/A
3/31/2021	69,788,729	14,802,019	-53,140,650	-49,008,273	N/A
12/31/2020	70,268,800	16,799,515	-21,798,738	-17,362,742	N/A
9/30/2020	69,558,773	21,260,138	-72,083,186	-67,484,768	N/A
6/30/2020	74,126,227	24,244,355	-17,388,822	-12,887,415	N/A
3/31/2020	79,171,686	28,164,908	-80,306,286	-75,610,912	N/A
12/31/2019	76,835,074	27,482,133	-78,246,587	-73,411,991	N/A
9/30/2019	76,027,346	27,173,159	-36,939,011	-33,242,436	N/A
6/30/2019	74,283,969	26,367,563	-54,750,281	-50,956,593	N/A
3/31/2019	73,705,983	26,388,234	-61,580,383	-57,840,590	N/A
12/31/2018	71,246,382	25,015,021	-61,031,952	-57,737,938	N/A
9/30/2018	67,586,337	23,662,323	-70,878,038	-67,640,360	N/A
6/30/2018	67,216,390	23,354,754	N/A	-61,983,351	N/A
3/31/2018	65,275,820	22,420,581	N/A	-34,609,807	N/A
12/31/2017	62,467,327	20,639,683	N/A	-47,717,816	N/A
9/30/2017	55,848,786	16,862,594	N/A	-50,356,492	N/A
6/30/2017	53,048,188	16,189,190	N/A	-52,609,707	N/A
3/31/2017	50,346,908	14,068,593	N/A	-37,382,619	N/A
12/31/2016	49,535,827	13,806,565	N/A	-43,796,675	N/A
9/30/2016	55,010,796	17,765,646	N/A	-35,953,738	N/A
6/30/2016	53,839,017	17,490,908	N/A	-17,260,879	N/A
3/31/2016	54,813,984	19,013,591	N/A	-36,902,726	N/A
12/31/2015	55,424,160	20,334,968	N/A	-24,111,371	N/A
9/30/2015	53,248,952	20,000,881	N/A	-30,706,227	N/A
6/30/2015	53,503,321	20,210,907	N/A	-62,902,058	N/A
3/31/2015	52,139,677	20,085,676	N/A	-56,106,318	N/A
12/31/2014	51,119,548	19,871,873	N/A	-62,440,155	N/A
9/30/2014	51,723,012	19,853,877	N/A	-49,873,307	N/A
6/30/2014	49,905,157	19,495,148	N/A	-40,083,737	N/A
3/31/2014	48,049,764	18,824,928	N/A	-56,596,916	N/A
12/31/2013	46,147,429	18,203,753	N/A	-58,091,206	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei BMRI ( 8.9% per jaar) ligt boven de spaarquote ( 6.8% ).

Winst versus markt: De winst van BMRI ( 8.9% per jaar) zal naar verwachting langzamer groeien dan de markt ID ( 19.8% per jaar).

Hoge groeiwinsten: De winst van BMRI zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van BMRI ( 12.3% per jaar) zal naar verwachting sneller groeien dan de markt ID ( 10.2% per jaar).

Hoge groei-inkomsten: De omzet van BMRI ( 12.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen BMRI zal naar verwachting over 3 jaar hoog zijn ( 20.9 %)

Bank Mandiri (Persero) Toekomstige groei

Future criteriumcontroles 3/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 7.3% to Rp6,402

Analysts update estimates

Recent updates

Third quarter 2024 earnings released: EPS: Rp166 (vs Rp98.80 in 3Q 2023)

President Director recently bought Rp1.1b worth of stock

Second quarter 2024 earnings: Revenues in line with analyst expectations

Vice President Director recently bought Rp1.0b worth of stock

Board Member recently bought Rp938m worth of stock

First quarter 2024 earnings released: EPS: Rp136 (vs Rp135 in 1Q 2023)

Now 23% overvalued after recent price rise

Dividend of Rp354 announced

Full year 2023 earnings released

Board Member recently bought Rp1.7m worth of stock

Board Member recently bought Rp878m worth of stock

Board Member recently bought Rp1.1b worth of stock

Board Member recently bought Rp1.5b worth of stock

Key Executive recently bought Rp1.1b worth of stock

President Director recently bought Rp580m worth of stock

Key Executive recently bought Rp1.3b worth of stock

Price target increased by 7.3% to Rp6,402

Second quarter 2023 earnings released: EPS: Rp272 (vs Rp109 in 2Q 2022)

First quarter 2023 earnings released: EPS: Rp135 (vs Rp108 in 1Q 2022)

Upcoming dividend of Rp529 per share at 3.6% yield

Full year 2022 earnings released

PT Bank Mandiri (Persero) Tbk to Report Q4, 2022 Results on Jan 31, 2023

No independent directors

Third quarter 2022 earnings released: EPS: Rp224 (vs Rp144 in 3Q 2021)

Second quarter 2022 earnings released: EPS: Rp218 (vs Rp141 in 2Q 2021)

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

No independent directors

Upcoming dividend of Rp361 per share

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Second quarter 2021 earnings released: EPS Rp141 (vs Rp51.01 in 2Q 2020)

New 90-day low: Rp6,250

Full year 2020 earnings released

New 90-day high: Rp6,950

New 90-day high: Rp6,800

New 90-day high: Rp6,375

Third quarter earnings released

New 90-day high - Rp6,250

Analysts update estimates

New 90-day high - Rp5,700

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven